Document is current
Any future updates will be listed below
-
Authors
Borges, Andreia
Pereira, Filipa
Redondo, Patrícia
Antunes, Luís
Vieira, Cláudia
Antunes, Pedro
Bento, Maria José
Sousa, Susana
Lopes, José Machado
Rocha-Gonçalves, Francisco
de Sousa, Joaquim Abreu
Pereira, Deolinda Sousa
Borges, Marina https://orcid.org/0000-0002-8073-6506
-
Funding
Funding for this research was provided by:
European Regional Development Fund
- License Information
-
More Information
Article History
Received: 21 January 2021
Accepted: 27 August 2021
First Online: 10 September 2021
Declarations
:
: This research received approval from the Local Ethics Committee (Comissão de Ética para a Saúde do Instituto Português de Oncologia do Porto FG - IPO-PORTO), followed all National ethical standards and procedures, and was performed in accordance with the Helsinki declaration.
: Not applicable.
: FP received financial support from Roche, Merck and Pfizer. PR, SS, JAS and DSP received financial support from Roche. CV received financial support from Roche, MSD, Novartis, Pfizer, Astrazeneca, Merck Serono, Grünenthal S.A. and Laboratorios Vitória. MB received financial support from Roche and Janssen. No financial support received was related to this article. AB, LA, PA, MJB, JML, FRG report no conflict of interests.
